Stem Med Pte Ltd is a biotechnology startup based in Singapore, specializing in the processing, cryopreservation, and storage of Bone Marrow and Peripheral Blood Stem Cells. The company's cellular laboratory is licensed by Singapore's Ministry of Health and equipped with ISO Class 5 clean rooms for sophisticated laboratory cell culturing.
Established in 2015, Stem Med is a joint venture between TalkMed Group Limited and StemCord, with a vision to become the premier stem cell bank, renowned for excellence and prowess in the field of stem cell therapy. The company offers stem cell banking services for long-term storage, emphasizing immediate or future therapeutic use.
Stem Med's mission is to help individuals maintain healthy lives and provide families with an additional treatment option for future disease treatment. The company is dedicated to pursuing excellence and innovation in regenerative medicine, with a focus on utilizing stem cells to promote health and offer new treatment options for diseases.
As a promising startup in the biotechnology sector, Stem Med presents an exciting opportunity for venture capital investors looking to support advancements in stem cell therapy and cellular therapeutics.
